Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,68 USD | -2,89 % | -17,65 % | -25,33 % |
21/03 | VOR BIOPHARMA INC. : recomendación de compra de Stifel Nicolaus | ZM |
21/03 | VOR BIOPHARMA INC. : El Oppenheimer continua con su recomendación de compra | ZM |
Resumen de negocios
Número de empleados: 168
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 07/08/19 |
Nathan Jorgensen
DFI | Director of Finance/CFO | 47 | 01/05/20 |
Chief Tech/Sci/R&D Officer | 51 | 01/10/19 | |
Eyal Attar
CTO | Chief Tech/Sci/R&D Officer | 53 | 12/10/22 |
Sarah Spencer
IRC | Investor Relations Contact | - | - |
Tania Philipp
HRO | Human Resources Officer | 52 | 01/12/19 |
John C. King
PRN | Corporate Officer/Principal | 49 | 01/08/20 |
General Counsel | 76 | 01/04/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 30/07/20 |
Matt Patterson
CHM | Chairman | 52 | 20/10/20 |
Bob Ang
CEO | Chief Executive Officer | 49 | 07/08/19 |
Bill Lundberg
BRD | Director/Board Member | 60 | 31/07/19 |
Daniella Beckman
BRD | Director/Board Member | 45 | 16/07/20 |
Joshua Resnick
BRD | Director/Board Member | 49 | 01/02/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 68 226 070 | 67 362 527 ( 98,73 %) | 10 299 ( 0,0151 %) | 98,73 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-25,33 % | 115 M | |
-1,82 % | 41,35 mil M | |
+42,78 % | 40,38 mil M | |
+2,56 % | 39,05 mil M | |
-12,11 % | 26,67 mil M | |
+3,09 % | 24,07 mil M | |
-24,16 % | 18,36 mil M | |
+22,12 % | 11,6 mil M | |
-3,74 % | 11,68 mil M | |
+7,75 % | 11,15 mil M |
- Bolsa de valores
- Acciones
- Acción VOR
- Empresa Vor Biopharma Inc.